Three out of four WHO HIV options pass muster

Author：  

Publisher： Adis International

ISSN： 1173-5503

Source： PharmacoEconomics and Outcomes News, Vol.1, Iss.620, 2011-01, pp. : 5-5

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Therapeutic options for HIV-associated lymphomas

By Spina Michele   Gloghini Annunziata   Tirelli Umberto   Carbone Antonino  

Expert Opinion on Pharmacotherapy, Vol. 11, Iss. 15, 2010-10 ,pp. : 2471-2481

Informa Healthcare

Access to resources Recommend Favorite

Maximising therapeutic options for HIV infection

By  

Inpharma, Vol. 1, Iss. 1351, 2002-01 ,pp. : 9-9

Adis International

Access to resources Recommend Favorite

WHO releases new HIV recommendations

By  

PharmacoEconomics and Outcomes News, Vol. 1, Iss. 593, 2009-01 ,pp. : 1-1

Adis International

Access to resources Recommend Favorite

Current treatment options to prevent perinatal transmission of HIV

By Mitchla Z.   Sharland M.  

Expert Opinion on Pharmacotherapy, Vol. 1, Iss. 2, 2000-01 ,pp. : 239-248

Informa Healthcare

Access to resources Recommend Favorite

Fosamprenavir: advancing HIV protease inhibitor treatment options

By Becker Stephen   Thornton Lorna  

Expert Opinion on Pharmacotherapy, Vol. 5, Iss. 9, 2004-09 ,pp. : 1995-2005

Informa Healthcare

Access to resources Recommend Favorite